Shastha Pharma Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.26 M
- Company Age 33 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 4.30 Cr
- Revenue Growth %
- Profit Growth 92.84%
- Ebitda 92.90%
- Net Worth -1.85%
- Total Assets -0.79%
About Shastha Pharma Laboratories
Shastha Pharma Laboratories Private Limited (SPLPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 December 1991 and has a history of 33 years and two months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.26 M.
The company has closed loans amounting to ₹4.30 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sural Raghavendramady and Sural Mady serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231KA1991PTC012570
-
Company No.
012570
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Dec 1991
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Shastha Pharma Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sural Raghavendramady
|
Director | 02-Dec-1991 | Current |
|
Sural Mady
|
Director | 02-Dec-1991 | Current |
Financial Performance of Shastha Pharma Laboratories.
Shastha Pharma Laboratories Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 92.84% increase in profit. The company's net worth dipped by a decrease of 1.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shastha Pharma Laboratories?
In 2019, Shastha Pharma Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Bangalore Pharmaceutical And Research Laboratory Private LimitedSural Raghavendramady and Sural Mady are mutual person
-
Bprl Healthcare Private LimitedSural Raghavendramady and Sural Mady are mutual person
Charges (Loans)
₹0
₹43.00 M
Charges Breakdown by Lending Institutions
- Karnataka Bank Ltd. : 4.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Jun 1994 | Karnataka Bank Ltd. | ₹2.00 M | Satisfied |
| 12 Feb 1994 | Karnataka Bank Ltd. | ₹4.10 Cr | Satisfied |
How Many Employees Work at Shastha Pharma Laboratories?
Unlock and access historical data on people associated with Shastha Pharma Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shastha Pharma Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shastha Pharma Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
